Cargando…
Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence
BACKGROUND: The S31N amantadine-resistance mutation in the influenza A M2 sequence currently occurs more frequently in nature than the S31 wild type. Overcoming the resistance of the S31N mutation is the primary focus of M2 researchers who aim to develop novel antiviral therapies. Recent studies hav...
Autores principales: | Durrant, Matthew G, Eggett, Dennis L, Busath, David D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423576/ https://www.ncbi.nlm.nih.gov/pubmed/25953496 http://dx.doi.org/10.1186/1471-2156-16-S2-S3 |
Ejemplares similares
-
Why Bound Amantadine Fails
to Inhibit Proton Conductance
According to Simulations of the Drug-Resistant Influenza A M2 (S31N)
por: Gleed, Mitchell L., et al.
Publicado: (2014) -
Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
por: Nguyen, Jack T., et al.
Publicado: (2012) -
Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization
por: Zhang, Yingjie, et al.
Publicado: (2013) -
Amantadine resistance among influenza A isolates in Sweden 2001–2006
por: Brytting, M., et al.
Publicado: (2006) -
Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2010)